Q&A: Psychedelics, cannabis, GLP-1s and drug policy changes

From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often more nuanced than the headlines suggest.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup